GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » PB Ratio

Raia Drogasil (BSP:RADL3) PB Ratio : 7.55 (As of May. 06, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-06), Raia Drogasil's share price is R$26.24. Raia Drogasil's Book Value per Share for the quarter that ended in Dec. 2023 was R$3.47. Hence, Raia Drogasil's PB Ratio of today is 7.55.

Good Sign:

Raia Drogasil SA stock PB Ratio (=7.55) is close to 1-year low of 7.16

The historical rank and industry rank for Raia Drogasil's PB Ratio or its related term are showing as below:

BSP:RADL3' s PB Ratio Range Over the Past 10 Years
Min: 2   Med: 7.48   Max: 10.68
Current: 7.55

During the past 13 years, Raia Drogasil's highest PB Ratio was 10.68. The lowest was 2.00. And the median was 7.48.

BSP:RADL3's PB Ratio is ranked worse than
88.67% of 600 companies
in the Healthcare Providers & Services industry
Industry Median: 2.245 vs BSP:RADL3: 7.55

During the past 12 months, Raia Drogasil's average Book Value Per Share Growth Rate was 11.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 11.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 10.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 10.10% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Raia Drogasil was 87.70% per year. The lowest was -15.80% per year. And the median was 10.80% per year.

Back to Basics: PB Ratio


Raia Drogasil PB Ratio Historical Data

The historical data trend for Raia Drogasil's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil PB Ratio Chart

Raia Drogasil Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.14 9.47 8.56 7.32 8.46

Raia Drogasil Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.32 7.38 9.17 8.27 8.46

Competitive Comparison of Raia Drogasil's PB Ratio

For the Pharmaceutical Retailers subindustry, Raia Drogasil's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's PB Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's PB Ratio distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's PB Ratio falls into.



Raia Drogasil PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Raia Drogasil's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=26.24/3.474
=7.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Raia Drogasil  (BSP:RADL3) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Raia Drogasil PB Ratio Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil (BSP:RADL3) Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines